Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 14, 2026 16:00 ET | Source: Spur Therapeutics

Spur Therapeutics Announces Executive Transitions

Spur Therapeutics Announces Executive Transitions
January 20, 2026 08:01 ET | Source: Spur Therapeutics

Spur Therapeutics Announces Platform and Poster Presentations Highlighting New Clinical Data for FLT201 in Gaucher Disease at Upcoming WORLDSymposium™

Spur Therapeutics to Present New Clinical Data on Its Gaucher Disease Gene Therapy Candidate at WORLDSymposium